Evidence map›Paper›PMID 23002006›Full record

ArticleArthritis and rheumatism2013

Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow.

Jie Li, Yawen Ju, Echoe M Bouta, Lianping Xing, Ronald W Wood, Igor Kuzin, Andrea Bottaro, Christopher T Ritchlin, Edward M Schwarz

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. The Function ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Fluorescent Tracers forFrontiers in pharmacology · 2022
    Review
  18. Article
  19. Frontiers in physiology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jie LiUniversity of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York 14642, USA.
Yawen Ju
Echoe M Bouta
Lianping Xing
Ronald W Wood
Igor Kuzin
Andrea Bottaro
Christopher T Ritchlin
Edward M Schwarz
University of Rochester · USUniversity of Rochester Medical Center · US

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI ANOLIK, JENNIFER HOWITT · 2010 to 2014
$10.8M
Elucidating the Mechanisms of Arthritic Flare and Developing TreatmentsR01AR056702 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2009 to 2025
$4.9M
Training in Orthopaedic Researchhttps://apps.era.nih.gov/grantfolder/viewInternalGF.era?applId=8841318&folderId=90T32AR053459 · NIAMS · UNIVERSITY OF ROCHESTER · PI ZUSCIK, MICHAEL J · 2006 to 2017
$3.4M
The University of Rochester Core Center for Musculoskeletal Biology and MedicineP30AR061307 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2011 to 2015
$3.0M
Role of TNFalpha in Osteoclast-Mediated Bone LossR01AR048697 · NIAMS · UNIVERSITY OF ROCHESTER · PI XING, LIANPING · 2002 to 2012
$2.6M
NCRR NIH HHS UL1 RR024160NIAID NIH HHS AI-78907NIAID NIH HHS P01 AI078907NIAMS NIH HHS AR-48697NIAMS NIH HHS AR-53459NIAMS NIH HHS AR-56702NIAMS NIH HHS AR-61307NIAMS NIH HHS P30 AR061307NIAMS NIH HHS R01 AR048697NIAMS NIH HHS R01 AR056702NIAMS NIH HHS T32 AR053459
6 · The paper itself

Abstract

objectiveB cell depletion therapy ameliorates rheumatoid arthritis by mechanisms that are incompletely understood. Arthritis flare in tumor necrosis factor (TNF)-transgenic mice is associated with efferent lymph node (LN) "collapse," triggered by B cell translocation into lymphatic spaces and decreased lymphatic drainage. The aim of this study was to examine whether the efficacy of B cell depletion therapy is associated with restoration of lymphatic drainage due to removal of obstructing nodal B cells.

methodsWe used contrast-enhanced magnetic resonance imaging, indocyanine green near-infrared imaging, and intravital immunofluorescence imaging to longitudinally assess synovitis, lymphatic flow, and cell migration in lymphatic vessels in TNF-transgenic mice. We conducted tests to determine whether the efficacy of B cell depletion therapy is associated with restoration of lymphatic draining and cell egress from arthritic joints.

resultsUnlike active lymphatics to normal and prearthritic knees, afferent lymphatic vessels to collapsed LNs in inflamed knees do not pulse. Intravital immunofluorescence imaging demonstrated that CD11b+ monocyte/macrophages in lymphatic vessels afferent to expanding LNs travel at high velocity (mean±SD 186±37 μm/second), while these cells are stationary in lymphatic vessels afferent to collapsed popliteal LNs. B cell depletion therapy for arthritis flares in TNF-transgenic mice significantly decreased knee synovium volume (by 50% from the baseline level) and significantly increased lymphatic clearance compared with placebo (P<0.05). This increased lymphatic drainage restored macrophage egress from inflamed joints without recovery of the lymphatic pulse.

conclusionThese results support a novel mechanism in which B cell depletion therapy for joint arthritis flares lessens inflammation by increasing lymphatic drainage and subsequent migration of cells and cytokines from the synovial space.

Indexed as

AnimalsArthritis, RheumatoidB-LymphocytesCD11b AntigenFlow CytometryImmunohistochemistryKnee JointLymphatic VesselsLymph NodesLymphocyte DepletionMagnetic Resonance ImagingMiceMice, TransgenicMicroscopy, FluorescenceSynovitisTreatment OutcomeCD11b AntigenITGAM protein, human

Identifiers

PMID23002006
PMCPMC3535508
OpenAlexW1965780190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.